scholarly journals The Critical Role of Patient Advocacy Groups in the Development of Rare Disease Gene Therapies

2018 ◽  
Vol 4 (7) ◽  
pp. 733-740
Author(s):  
Susan Wilson ◽  
Elisabeth Linton
2004 ◽  
Vol 28 (2) ◽  
pp. 228 ◽  
Author(s):  
Hans Lofgren

Consumer and patient advocacy groups (PAGs) are important participants in the politics of pharmaceuticals. Yet very little is known about the precise nature and extent of their influence. It is argued in this article that PAGs fulfil a mixed role within the health system at national and transnational levels, and that they are at times fully incorporated into economic and political power structures. Their frequent dependence on pharma industry funding is of particular concern. PAGs provide a means of direct industry interaction with the final customer, thereby partially bypassing and putting additional pressure on doctors and regulators. The article presents the case for research to establish a better empirical base for discussions about the role of PAGs within contemporary neoliberal governance structures.


2017 ◽  
Vol 10 (1) ◽  
pp. 33-35 ◽  
Author(s):  
Eleni Tsigas

Advocacy has a critical role in advancing the maternal health agenda. Patient advocacy groups can hold governments and other stakeholders accountable and ensure that commitments are translated into concrete action. This article highlights the advocacy efforts of the Preeclampsia Foundation, a patient advocacy organisation that aims to improve the diagnosis, management, and prevention of pre-eclampsia through research and improved healthcare practices. A number of challenges continue to face maternal health advocacy especially in low- and middle-income countries. Future directions include developing a strategic focus for advocacy, effectively engaging citizens to build a culture of accountability, and monitoring and evaluation of advocacy efforts.


Sign in / Sign up

Export Citation Format

Share Document